Top Videos
Top Searches
Shuren Fda
What is CDRH doing to accelerate the regulatory pathway for innovative medical technologies?
6:16
|
EP. 2 Jeffrey Shuren on FDA-sponsor interactions: Where they’ve been and where they’re going
29:01
|
Jeffrey Shuren, director of FDA's CDRH will make end year (2011) announcement on amalgam rule
4:36
|
FDA official testifies regarding laboratory developed tests (LDTs)
4:02
|
CDRH Center Director Jeff Shuren on why FDA invests in MDIC
0:56
|
Total Product Lifecycle Advisory Program (TAP) Engagement with Device Developers
4:16
|
Reporting on MassMEDIC's Regulatory Roundup
7:32
|
Did FDA's Jeffrey Shuren lie under oath about Google-backed 23andMe?
4:58
|
US FDA CDRH Director Jeff Shuren presents at the MDIC 2015 Annual Public Forum
10:51
|
MDUFA IV and Beyond: Video Reports
9:24
|
What's most important for innovators to understand about FDA's new mobile health guideline?
3:01
|
CDRH Center Director Jeff Shuren on MDIC's Patient Preference Framework
1:11
|
07/18/2018 - Session VI: Shuren
13:41
|
Safety Signal Transparency: Using the Power of Data
34:48
|
FDA Updated QSR – 21 CFR, Part 820 Information
1:21
|
FDA Roundtable
48:31
|
Regulatory Education for Industry (REdI) Annual Conference 2023 – FDA Welcome and Keynote
1:48:29
|
Town Hall Meeting with the FDA's Jeff Shuren at the 2023 Utah Life Sciences Summit
45:24
|
Conversation with Dr. Jeff Shuren
48:09
|
How is CDRH encouraging more US-based first-in-human studies?
1:34
|
← Previous
500
Next →